IPO registrations (S-1, F-1) · Registrants
20/20 Biolabs, Inc.
- SEC CIK
- 1139685 · filings on EDGAR ↗
- Former names
- 20/20 GeneSystems, Inc. (2015–2025); 20/20 GENE SYSTEMS INC (2002–2004)
- Registration
- Form S-1, first filed 2025-12-12, last 2026-04-06; 2 initial registrations, 2 amendments
- Outcome
- Declared effective 2026-02-17
- Industry (SIC)
- Services-Testing Laboratories 8734
- Incorporated in
- DE
- Business address
- 9430 KEY WEST AVENUE, SUITE 100, Rockville, MD 20850
- EIN
- 52-2272107
- Ticker
- AIDX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- 20/20 Biolabs, Inc. on the corporate pages
Offering terms
- Shares offered
- 10,105,000
- Listing
- Nasdaq under the symbol AIDX
- Lead underwriters
- of Contents
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: 20 20 GENE SYSTEMS INC EXACT (EIN (EXACT))
- Federal award recipient: 20/20 BIOLABS, INC. Fuzzy (name and state)
- Form D issuer: 20/20 GeneSystems, Inc. EXACT (CIK (EXACT))
- SEC filer: 20/20 Biolabs, Inc. EXACT (CIK (EXACT))
- Person page: John G Compton Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2025-12-12 | S-1 | S-1 (registration) | 20/20 Biolabs, Inc. | 0001213900-25-121285 ↗ |
| 2026-01-21 | S-1/A | S-1/A (amendment) | 20/20 Biolabs, Inc. | 0001213900-26-006263 ↗ |
| 2026-01-26 | S-1/A | S-1/A (amendment) | 20/20 Biolabs, Inc. | 0001213900-26-007650 ↗ |
| 2026-02-17 | EFFECT | EFFECT (declared effective) | 20/20 Biolabs, Inc. | 9999999995-26-000603 ↗ |
| 2026-04-06 | S-1 | S-1 (registration) | 20/20 Biolabs, Inc. | 0001213900-26-040553 ↗ |
| 2026-04-09 | EFFECT | EFFECT (declared effective) | 20/20 Biolabs, Inc. | 9999999995-26-001126 ↗ |
| 2026-04-10 | EFFECT | EFFECT (declared effective) | 20/20 Biolabs, Inc. | 9999999995-26-001159 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | S-1 | registration statement | $1.89 | 10,105,000 | $19,098,450 | Nasdaq AIDX | 1 | primary document; price line, shares headline, proceeds computed, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Baker Ron | Officer | Chief Business Officer | 1 | 2026 | |
| Bergman Alan B. | Officer | Chief Financial Officer | 2 | 2026 | |
| COHEN RICHARD M | Director | 2 | 2026 | ||
| Compton John G. | Director | 2 | 2026 | person page Fuzzy | |
| Lebowitz Michael Saul | Officer | Chief Scientific Officer | 1 | 2026 | |
| Reddy Prasanth | Director | 1 | 2026 | ||
| Ross Michael A. | Director | 2 | 2026 | ||
| Zhou Jiming | Officer | Chief Operating Officer | 2 | 2026 | |
| Cohen Jonathan M | Director,Officer,TenPercentOwner | Chief Executive Officer | 2 | 2026 | |
| Rollins John Woodson | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-02-26 | 20/20 GeneSystems, Inc. | Biotechnology | $3,000,000 | $70,000 | 3 | 1 |
| 2016-02-04 | 20/20 GeneSystems, Inc. | Biotechnology | $3,000,000 | $2,000,000 | 1 | 1 |
| 2015-09-22 | 20/20 GeneSystems, Inc. | Biotechnology | $4,000,000 | $2,513,413 | 66 | 3 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | 20 20 GENE SYSTEMS INC | MD | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | 20/20 BIOLABS, INC. | MD | Federal spending (USAspending) | name and state |
| Form D issuer | 20/20 GeneSystems, Inc. | MD | Form D private offerings | CIK (EXACT) |
| SEC filer | 20/20 Biolabs, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | 20/20 Biolabs, Inc. | MD | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | 20 20 GENE SYSTEMS INC | EIN (EXACT) | ||
| Person page | John G Compton | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Testing Laboratories, MD first:
- NEOGENOMICS INC FL
- Medytox Solutions, Inc. FL
- GREENSCAPE LABORATORIES, INC. FL
- UL Solutions Inc. IL
- AAIPHARMA INC NC
- ORCHID CELLMARK INC NJ
- ERESEARCHTECHNOLOGY INC /DE/ PA
In other datasets, the same topic (Science) in MD:
- Nonprofit: ABET FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Services-Testing Laboratories · Science